CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patientsMULEY, Thomas; DIENEMANN, Hendrik; EBERT, Werner et al.Anticancer research. 2004, Vol 24, Num 3B, pp 1953-1956, issn 0250-7005, 4 p.Article

Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLCMULEY, Thomas; DIENEMANN, Hendrik; EBERT, Werner et al.Anticancer research. 2003, Vol 23, Num 5B, pp 4085-4093, issn 0250-7005, 9 p.Article

Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumoursLA ROSA, S; RIGOLI, E; UCCELLA, S et al.Histopathology. 2007, Vol 50, Num 5, pp 597-606, issn 0309-0167, 10 p.Article

Implementation of Molecular Intra-operative Assessment of Sentinel Lymph Node in Breast CancerKHADDAGE, Abir; BERREMILA, Sid-Ali; FOREST, Fabien et al.Anticancer research. 2011, Vol 31, Num 2, pp 585-590, issn 0250-7005, 6 p.Article

Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epitheliumOKUMURA, Tomoyuki; WANG, Sophie S. W; TAKAISHI, Shigeo et al.Laboratory investigation. 2009, Vol 89, Num 12, pp 1410-1422, issn 0023-6837, 13 p.Article

Increased levels of IgG to cytokeratin 19 in sera of patients with toluene diisocyanate-induced asthmaCHOI, Jung-Hee; NAHM, Dong-Ho; KIM, Seung-Hyun et al.Annals of allergy, asthma, & immunology. 2004, Vol 93, Num 3, pp 293-298, issn 1081-1206, 6 p.Article

Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancyDE MATOS, P. S; FERREIRA, A. P; DE OLIVEIRA FACURI, F et al.Histopathology. 2005, Vol 47, Num 4, pp 391-401, issn 0309-0167, 11 p.Article

CYFRA 21-1 determination in patients with esophageal squamous cell carcinoma : Clinical utility for detection of recurrencesKAWAGUCHI, Hidetoshi; OHNO, Shinji; MIYAZAKI, Mitsuhiro et al.Cancer. 2000, Vol 89, Num 7, pp 1413-1417, issn 0008-543XArticle

Cyfra 21-1 : a serological help for detection of distant metastases in head and neck cancerMAASS, J. D; HOFFMANN-FAZEL, A; GOEROEGH, T et al.Anticancer research. 2000, Vol 20, Num 3B, pp 2241-2243, issn 0250-7005Article

Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumorsDESHPANDE, Vikram; FERNANDEZ-DEL CASTILLO, Carlos; MUZIKANSKY, Alona et al.The American journal of surgical pathology. 2004, Vol 28, Num 9, pp 1145-1153, issn 0147-5185, 9 p.Article

Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patientsALVERO, Ayesha B; BURTNESS, Barbara A; ERCAN, Adife Gulhan et al.Laboratory investigation. 2004, Vol 84, Num 5, pp 658-661, issn 0023-6837, 4 p.Article

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrenceUENISHI, Takahiro; KUBO, Shoji; YAMAMOTO, Takatsugu et al.Cancer science. 2003, Vol 94, Num 10, pp 851-857, issn 1347-9032, 7 p.Article

Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinomaNAKATA, Bunzo; OGAWA, Yoshinari; ISHIKAWA, Tetsuro et al.Cancer. 2000, Vol 89, Num 6, pp 1285-1290, issn 0008-543XArticle

Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancerBROCKMANN, Jens G; NOTTBERG, Hubertus St; GLODNY, Bernhard et al.Anticancer research. 2000, Vol 20, Num 6D, pp 4899-4904, issn 0250-7005Article

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent diseaseDOWECK, I; BARAK, M; URI, N et al.British journal of cancer. 2000, Vol 83, Num 12, pp 1696-1701, issn 0007-0920Article

Fine-needle aspiration biopsy of papillary thyroid carcinoma: Diagnostic utility of cytokeratin 19 immunostainingNASSER, Selim M; PITMAN, Martha B; PILCH, Ben Z et al.Cancer. 2000, Vol 90, Num 5, pp 307-311, issn 0008-543XArticle

Neurogenic Differentiation 1 Directs Differentiation of Cytokeratin 19-Positive Human Pancreatic Nonendocrine Cells into Insulin-Producing CellsSHIMODA, M; CHEN, S; NOGUCHI, H et al.Transplantation proceedings. 2010, Vol 42, Num 6, pp 2071-2074, issn 0041-1345, 4 p.Conference Paper

Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significanceSTATHOPOULOU, A; VLACHONIKOLIS, I; REPPA, D et al.Journal of clinical oncology. 2002, Vol 20, Num 16, pp 3404-3412, issn 0732-183XArticle

Dose-Related Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in C57BL/6 MiceKUSHIDA, Masahiko; KAMENDULIS, Lisa M; PEAT, Tyler J et al.Toxicologic pathology. 2011, Vol 39, Num 5, pp 776-786, issn 0192-6233, 11 p.Article

Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancerVISSER, Mike; JIWA, Mehdi; HORSTMAN, Anja et al.International journal of cancer. 2008, Vol 122, Num 11, pp 2562-2567, issn 0020-7136, 6 p.Article

Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinomaLEE, Jae-Eun; OH, Bong-Kyeong; CHOI, Jinsub et al.International journal of cancer. 2008, Vol 123, Num 2, pp 264-272, issn 0020-7136, 9 p.Article

CYFRA21-1 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinomaYAN YI; BAOSHENG LI; ZHONGTANG WANG et al.Biomarkers (London. Print). 2009, Vol 14, Num 7, pp 480-485, issn 1354-750X, 6 p.Article

Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancerVARANGOT, Mario; BARRIOS, Enrique; SONORA, Cecilia et al.Oncology reports. 2005, Vol 14, Num 2, pp 537-545, issn 1021-335X, 9 p.Article

Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumorsISIC, Tijana; SAVIN, Svetlana; CVEJIC, Dubravka et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 12, pp 1805-1812, issn 0171-5216, 8 p.Article

Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapyHOLDENRIEDER, Stefan; HOLUBEC, Lubos JR; TOPOLCAN, Ondrej et al.Anticancer research. 2005, Vol 25, Num 3A, pp 1795-1801, issn 0250-7005, 7 p.Article